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Interaction of adipose-derived mesenchymal stem cells with MCF-7 cells in vitro:
a study emphasizing signaling molecule expression and transcriptional changes
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Abstract: Adipose-derived stem cells (ADSCs) promote metastasis of breast cancer cells that can differentiate into carcinoma-associated
cells in tumor microenvironments. However, the precise mechanism is poorly understood. This study shows that interaction of ADSCs
with breast cancer MCF-7 cells changes the level of metastasis-related functional proteins in MCF-7 cells, as well as that of oncogenes in
ADSCs. ADSCs were isolated from adipose tissues of patients. The interaction of ADSCs with MCF-7 cells was performed by coculturing
ADSCs (or MCF-7 cells) with exosomes derived from MCF-7 cells (or ADSCs). Exosomes were labeled by DiI. In cocultures, migrationrelated regulators in MCF-7 cells were significantly enhanced in both protein (Smad, Slug, Snail1/2, Twist1, N-cadherin, vimentin) and
mRNA (SMAD, SLUG, SNAIL1/2, TWIST1, N-cadherin, and vimentin) levels. The expression levels of oncogenes (RAS and HER-2)
and an antioncogene gene (P53) in ADSCs were upregulated and downregulated, respectively. Interestingly, variation tendencies of the
molecules were more conspicuous in inflammatory circumstances than without. In conclusion, interaction of MCF-7 cells with ADSCs
increases the levels of a series of metastasis-related functional proteins in MCF-7 cells and enhances the expression of oncogenes in
ADSCs.
Key words: Adipose-derived stem cells, metastasis, functional proteins, oncogene

1. Introduction
Adipose-derived mesenchymal stem cells (ADSCs) are
a heterogeneous population of adult stem cells derived
from adipose tissue. ADSCs functionally differentiate
into various cell lineages in a special microenvironment
(Uzbas et al., 2015). ADSCs are autologous, available in
sufficient quantities in most patients, and are widely used
in soft tissue repair, for instance, in breast reconstruction
in surgical patients (Rowan et al., 2014). However, recent
papers indicate ADSCs potentially induce a tumor
microenvironment and affect tumor cell biology. In
mammary tissue (Muehlberg et al., 2009), resident stem
cells promote breast cancer metastasis, home to the
tumor site, and stimulate tumor growth not only when
coinjected locally but also when injected intravenously.
Kucerova et al. (2011) reported that ADSCs could
stimulate proliferation of several breast cancer cells in
vitro, such as MDA-MB-361, T47D, and EGFP-MCF-7.
Kim et al. (2013) found that breast and abdominal adipose
tissues have comparable gene expression profiles and are
comparable in supporting breast cancer cell proliferation
and metastasis. On the other hand, it has been previously
* Correspondence: liyuejun009@sina.com

reported that the morphology and phenotype of ADSCs
are altered when cocultured with tumor cells. ADSCs
(Jotzu et al., 2011) that received tumor-derived factors
differentiated into carcinoma-associated fibroblast-like
cells, which functionally contribute to tumor growth,
invasion, and metastasis. ADSCs directly cocultured with
H358 lung cancer cells differentiated into tumor stroma
that play a supportive role during cancer progression (Park
et al., 2013).
Of note, except for the diffusible factors (cytokines,
chemokine, and growth factors), cell-derived exosomes
have been described as a new signal in cell-to-cell
communication. Exosomes are membrane vesicles (30–
100 nm) from luminal membranes of multivesicular
bodies and are constitutively released upon fusion with
cell membranes (Tan et al., 2016). It has been previously
confirmed that ADSCs secrete exosomes (Cho et al., 2012;
Lin et al., 2013), promote MCF-7 cell migration, and that
exosomes from breast cancer cells convert ADSCs into
myofibroblast-like cells. These results provide evidence
that exosomes play a role in crosstalk between ADSCs and
MCF-7 cells.
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Epithelial to mesenchymal transition (EMT) is
involved in tumor cell metastasis and serves as the first
step in the migration of tumor cells (Kumar et al., 2015).
During EMT formation, numerous functional intracellular
signaling pathways (TGFβ-Smad) and functional proteins,
such as SMAD, SLUG, SNAIL1/2, TWIST1, N-cadherin,
and vimentin, are significantly disturbed (Yamada et al.,
2014). P53, HER-2, and RAS are well known for their roles
in regulation of cell growth, differentiation, and survival,
and are usually considered classical markers of carcinoma
cells (Shin et al., 2013). However, the mechanisms of
communication of ADSCs and tumor cells are still unclear.
The aim of this study was to investigate signal molecular
alteration of ADSCs (or MCF-7 cells) in the presence of
exosomes derived from MCF-7 cells (or ADSCs).
2. Materials and methods
2.1. Reagents
Lipopolysaccharide (LPS) and polyinosinic: polycytidylic
acid (poly (I:C)) were acquired from Sigma-Aldrich (St.
Louis, MO, USA). Primary antibodies for Slug (sc-166476),
Snail1/2 (sc-393172), Smad (sc-10486), Twist1 (sc-6269),
E-cadherin (sc-71008), N-cadherin (sc-53488), vimentin
(sc-373717), P53 (sc-47698), HER-2 (sc- 33684), and RAS
(sc-271436) were obtained from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA, USA). Primary antibodies for CD29
(ab58603), CD90 (ab92574), CD34 (ab8536), and CD45
(ab40763) were purchased from Abcam (Cambridge, MA,
USA). Secondary antibodies (goat antimouse/BA1050,
goat antirabbit/BA1054) were purchased from Boster, Ltd.
(Wuhan, China). All chemicals used in the present study
were of analytical grade.
2.2. Cell culture
ADSCs were prepared according to the method described
previously (Lin et al., 2013). This study was approved by
the ethics committee of the affiliated Zhujiang Hospital
of Southern Medical University (Guangzhou, China).
Informed consent was obtained from all the participants.
Briefly, ADSCs were isolated from adipose tissues of
patients undergoing tumescent liposuction. The cells
were cultured in 75 cm2 culture flasks and incubated in
a humidiﬁed environment containing 5% CO2 at 37 °C.
Passage 0 ADSCs were cultured using regular growth
medium, which contained 58% Dulbecco’s modiﬁed
Eagle’s medium/Ham’s F-12 medium (Gibco, Grand
Island, NY, USA), 40% medium complete with trace
elements-201 (Gibco), 2% fetal bovine serum (Gibco),
1 × 109 mol/L insulin-transferrin-selenium (Gibco), 1 ×
109 mol/L dexamethasone, 1 × 109 mol/L ascorbic acid-2phosphate, 20 ng/mL IL-6, 10 ng/mL epidermal growth
factor, 10 ng/mL platelet-derived growth factor BB (all
from Sigma-Aldrich), 100 U/mL penicillin, and 100
mg/mL streptomycin. Passage 5 cells were used for the
following study.
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MCF-7 breast cancer cells were purchased from
Cancer Institute of Chinese Academy of Medical Sciences
(Beijing, China). MCF-7 cells were cultured in complete
DMEM containing 10% fetal bovine serum, penicillin
(100 U/mL), and streptomycin (100 U/mL) at 37 °C in air
with 5% CO2.

2.3. Flow cytometric analysis of CD surface markers on
ADSCs
For flow cytometric analysis of phenotype in ADSCs,
cells in passage 5 were treated with 0.05% trypsin-0.53
mM EDTA, and washed twice with PBS. Cell aliquots (1
× 105 cells/100 μL) were stained with primary-conjugated
antibodies at room temperature for 30 min. The conjugated
antibodies used for these experiments were PE-conjugated
antihuman CD29, CD34, CD45, and CD90. Appropriate
fluorescein- or phycoerythrin- conjugated isotypes were
used as a control for each assay. Flow cytometric analysis
used a flow cytometer (FACSCalibur; Becton-Dickinson,
San Jose, CA, USA). The results were processed with Cell
Quest Software (Becton-Dickinson) for statistical analyses.
2.4. Exosome extraction and quantiﬁcation
Exosomes were prepared according to the methods
published previously (Singh et al., 2014). ADSC (or MCF7) culture medium (48 h) was collected and centrifuged at
500 × g for 10 min and then recentrifuged at 2000 × g for
20 min to remove cells. The supernatant was subjected to
filtration on a 0.1-mm-pore polyethersulfone membrane
filter (Corning, Inc., Corning, NY, USA) to remove cell
debris and large vesicles, followed by concentration by a
100,000 Mw cut-off membrane (CentriPlus-70; Millipore,
Billerica, MA, USA). The supernatant volume was reduced
from approximately 250–500 mL to 25 mL. Subsequently,
the supernatant was filtered using a 0.22 µm filter
(Millipore), and condensed fluids were ultracentrifuged at
100,000 × g for 1 h at 4 °C using a 70Ti rotor (Beckman
Coulter, Brea, CA, USA). Finally, the pellets were
resuspended in PBS and ultracentrifuged at 100,000 × g for
another 1 h at 4 °C using a 100Ti rotor (Beckman Coulter).
Puriﬁed exosomes were labeled with 1 M DiI (Invitrogen,
Carlsbad, CA, USA) as previously described (Hood et al.,
2009). The exosomes were washed to remove unbound DiI
and then resuspended in PBS for further use.
The number of exosomes was quantified to determine
the protein concentration of exosomes. Exosomal proteins
from the supernatant of the cells after exosomal isolation
were quantified using the Bradford method. In particular,
the actual protein concentrations were calculated using
the standard curve equation and the appropriate dilutions.
2.5. Interaction of ADSCs with MCF-7 cells
To study the interaction of ADSCs with MCF-7 cells during
tumor progression under inflammatory environments,
LPS and poly (I:C), which stimulate cells that produce
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proinflammatory cytokines, were used to activate ADSCs
and MCF-7 cells. Cocultured groups in vitro were set as
following: MCF-7 cells, MCF-7 cells cultured with ADSCsecreted exosomes (100 µg/mL, 200 µg/mL), MCF-7 cells
cultured with ADSC exosomes stimulated by 5 µg/mL
LPS (100 µg/mL, 200 µg/mL), MCF-7 cells cultured with
ADSC exosomes treated with 20 µg/mL poly (I:C) (100
µg/mL, 200 µg/mL), ADSCs, ADSCs cultured with MCF7–released exosomes (100 µg/mL, 200 µg/mL), ADSCs
cultured with exosomes from LPS-stimulated MCF-7 cells
(100 µg/mL, 200 µg/mL), ADSCs cultured with exosomes
from poly (I:C)-stimulated MCF-7 cells (100 µg/mL, 200
µg/mL). The time for coculture was designated as 48 h.
2.6. Western blotting
Cultured medium was removed and residual cells were
washed 3 times with PBS. Subsequently, the cells were mixed
with lysates for 30 min, and the lysates were centrifuged
at 12,000 rpm for 15 min to separate the supernatant.
The protein levels in the supernatant were quantified
by BCA Protein Kit (Thermo Scientiﬁc, Waltham, MA,
USA). Western blotting analysis (Kruger et al., 2014)
was performed to evaluate the levels of target proteins.
Briefly, the samples were separated in SDS polyacrylamide
gels. The membranes (Millipore) were incubated with
primary antibodies followed by shaking overnight at 4 °C.
The following antibodies and concentrations were used:
1:1000 (Smad), 1:1000 (Slug), 1:1000 (Snail1/2), 1:1000
(Twist1), 1:2500 (E-cadherin), 1:2500 (N-cadherin),

1:1000 (vimentin), 1:1000 (RAS), 1:1000 (P53), and 1:1000
(HER-2). After that, the membranes were incubated with
corresponding secondary antibodies (Boster, Ltd.) for
another 2 h at room temperature. Finally, immunodetection
was visualized by a chemiluminescent ECL reagent
(Pierce Biotechnology, Inc., Waltham, MA, USA). Three
independent experiments were performed, and average
results were recorded. The quantification of proteins was
analyzed by IPP software (Media Cybernetics, Rockville,
MD, USA).
2.7. Real-time quantitative polymerase chain reaction
Total RNA was extracted from the cells by TRIzol reagent
(Invitrogen) according to the instructions. RNA levels were
evaluated by real-time reverse-transcription polymerase
chain reaction (RT-PCR) with the SYBR Prime Script
RT-PCR kit (Takara, Kusatsu, Japan). The PCR primers
designed by Sangon Biotech (Shanghai, China) are listed in
the Table. β-Actin was used to normalize gene expression
in each experiment. PCR efficiency was first determined
by β-actin to ensure that the normalizing genes were
acceptable and to test primer efficiency. Relative levels
of gene expression (amount of target gene normalized to
the endogenous control gene) were calculated using the
comparative Ct method formula 2−△△CT offered by BioRad CFX Manager Software 1.6.
2.8. Statistical analysis
Data are presented as means ± SE. Comparisons among
groups were carried out using one-way analysis of variance

Table. Primer sequences used.
Gene

Gene ID

Primer

Primer sequence

SLUG

NM_003068.4

Forward

agacccccatgccattgaag

Reverse

cttctcccccgtgtgagttc

Forward

accccacatccttctcactg

Reverse

tacaaaaacccacgcagaca

Forward

atccagcagattctgggatg

Reverse

aggatggcccagagaatctt

Forward

gtccgcagtcttacgaggag

Reverse

ccagcttgagggtctgaatc

SNAIL1/2
SMAD2
TWIST1
E-cadherin
N-cadherin

NM_005985.3
NM_001003652.3
NM_000474.3
NM_004360.3
NM_001308176.1

Forward

tgcccagaaaatgaaaaagg

Reverse

gtgtatgtggcaatgcgttc

Forward

gacaatgcccctcaagtgtt

Reverse

ccattaagccgagtgatggt

Vimentin

NM_003380.3

Forward

gagaactttgccgttgaagc

Reverse

tccagcagcttcctgtaggt

ACTIN

NM_001102.3

Forward

gcacccttcaacaactggat

Reverse

gatggttgtgtaggggttgg
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(ANOVA) followed by Student’s t-test (SPSS version 12;
SPSS Software Products, Chicago, IL, USA). A difference
was considered to be significant at P < 0.05.
3. Results
3.1. Identiﬁcation and characterization of ADSCs
The phenotype of ADSCs in passage 5 was analyzed for
different antibodies typically expressed by mesenchymal
stem cells. Flow cytometric analysis (Figure 1) showed that
ADSCs were positive for mesenchymal stem cell markers
CD29 and CD90 and were negative for CD34 and CD45,
which preclude contamination with hematopoietic cells.
3.2. Effects of ADSC-secreted exosomes on the mRNA
levels of functional proteins in MCF-7 cells
To investigate the effects of ADSCs on the metastasisrelated functional proteins of MCF-7, 5.0 × 104 ADSCs were
cultured in conditioned growth media for 48 h. Exosomes

from ADSC culture media were extracted and used to
stimulate MCF-7 cells for 48 h at two levels (exosome L:
100 µg/mL; exosome H: 200 µg/mL). To characterize the
transcriptional changes of MCF-7 cells, the mRNA profiles
of functional proteins were analyzed. As seen in Figure
2A, after treatment with ADSC-derived exosomes, SMAD,
SLUG, SNAIL1/2, TWIST1, N-cadherin, and vimentin
mRNA were obviously upregulated (P < 0.01), while levels
of E-cadherin were observably reduced (P < 0.01). LPS is
a component of the outer membrane of gram-negative
bacteria, and can trigger an immune response. Poly (I:C)
is a synthetic analog of double-stranded RNA and is
usually used as a vaccine adjuvant to enhance innate and
adaptive immune responses (Durai et al., 2015; Reisinger
et al., 2015). Inflammatory responses can speed up tumor
progression; accordingly, to investigate the interaction of
ADSCs with MCF-7 cells in an inflammatory environment,
LPS and poly (I:C) (which stimulate cells that produce

Figure 1. ADSCs express CD surface markers typical for mesenchymal stem cells. Flow cytometric
analysis of CD surface markers on ADSCs.
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Figure 2. ADSC-secreted exosomes changed the mRNA levels of functional proteins in MCF-7 cells. A: Compared with that of
control group, ADSC-secreted exosomes increased mRNA levels of SMAD, SLUG, SNAIL1/2, TWIST1, N-cadherin, and vimentin and
meanwhile reduced the levels of E-cadherin in MCF-7 cells; exosome L: 100 µg/mL; exosome H: 200 µg/mL. B: Compared with the
control group, exosomes from LPS- or poly (I:C)-treated ADSCs significantly increased mRNA levels of SMAD, SLUG, SNAIL1/2,
TWIST1, N-cadherin, vimentin, and reduced the levels of E-cadherin in MCF-7 cells. 1: Control group (MCF-7 cells without exosome
treatment); 2: MCF-7 cells treated with 100 µg/mL exosomes from LPS-stimulated ADSCs; 3: MCF-7 cells treated with 200 µg/mL
exosomes from LPS-stimulated ADSCs; 4: MCF-7 cells treated with 100 µg/mL exosomes from poly (I:C)-stimulated ADSCs; 5: MCF-7
cells treated with 200 µg/mL exosomes from poly (I:C)-stimulated ADSCs. **P < 0.01 compared to group 1. Data are shown as the means
of three parallel experiments.

proinflammatory cytokines) were used to activate ADSCs
or MCF-7 cells. As expected, the exosomes of LPS- or
poly (I:C)-treated ADSCs altered these regulators in the
same manner as exosomes from the LPS- or poly (I:C)untreated ADSC group (P < 0.01, Figure 2B).
3.3. Effects of ADSC-secreted exosomes on the expression
of functional proteins in MCF-7 cells
As shown in Figures 3A and 3B, treatment with ADSCderived exosomes significantly increased expression of

Smad, Slug, Snail1/2, Twist1, N-cadherin, and vimentin,
and reduced the levels of E-cadherin in MCF-7 cells
compared with those in untreated MCF-7 cells (P < 0.01).
In addition to studying the prometastasizing activity of
ADSCs under inflammatory environments, the levels
of the functional proteins in MCF-7 cells stimulated by
ADSC exosomes in the presence of LPS or poly (I:C) were
investigated. The results in Figures 3C and 3D showed that
LPS- or poly (I:C)-treated ADSC exosomes changed the
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Figure 3. ADSC-secreted exosomes altered the expression of functional proteins in MCF-7 cells. A: Representative protein
bands, exosome L: 100 µg/mL; exosome H: 200 µg/mL. B: Densitometric analysis of Figure 3A. ADSC-secreted exosomes
significantly increased the levels of Smad, Slug, Snail1/2, Twist1, N-cadherin, and vimentin and reduced the level of
E-cadherin in MCF-7 cells compared with the control group. 1: Control group (MCF-7 cells without exosomes treatment),
2: MCF-7 cells treated with 100 µg/mL exosomes, 3: MCF-7 cells treated with 200 µg/mL exosomes. **P < 0.01 compared
to group 1. Data are shown as the means of three parallel experiments. C: representative protein bands, +a: exosomes with
a concentration of 100 µg/mL; +b: exosomes with a concentration of 200 µg/mL. D: Densitometric analysis of Figure 3C.
Exosomes significantly increased levels of Smad, Slug, Snail1/2, Twist1, N-cadherin, and vimentin and reduced the levels
of E-cadherin in MCF-7 cells compared to the control group. 1: Control group (MCF-7 cells without exosomes treatment),
2: MCF-7 cells treated with 100 µg/mL exosomes from LPS-stimulated ADSCs, 3: MCF-7 cells treated with 200 µg/mL
exosomes from LPS-stimulated ADSCs, 4: MCF-7 cells treated with 100 µg/mL exosomes from poly (I:C)-stimulated
ADSCs; 4: MCF-7 cells treated with 200 µg/mL exosomes from poly (I:C)-stimulated ADSCs. **P < 0.01 compared to group
1. Data are shown as the means of three parallel experiments.

expressions of Smad, Slug, Snail1/2, Twist1, N-cadherin,
vimentin, and E-cadherin in the same manner as exosomes
from the LPS- or poly (I:C)-untreated ADSC group (P <
0.01).
3.4. Effects of MCF-7 cells produced exosomes on the
mRNA levels of RAS, P53, and HER-2 in ADSCs
To further characterize the oncogenes in ADSCs, the
mRNA levels of RAS, P53, and HER-2 in ADSCs were
analyzed. The results in Figure 4A show that MCF-7–
derived exosomes caused obvious upregulation in the
expression of RAS and HER-2 and a decrease in the levels
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of P53 in ADSCs (P < 0.01). Similarly, MCF-7–produced
exosomes in the presence of LPS or poly (I:C) increased
RAS and HER-2 mRNA levels and lowered P53 level in
ADSCs as well (Figure 4B; P < 0.01).
3.5. Effects of MCF-7 cells produced exosomes on the
protein levels of RAS, P53, and HER-2 in ADSCs
As presented in Figures 5A and 5B, treatment with MCF7–derived exosomes significantly increased expression of
RAS and HER-2, and decreased the level of P53 in ADSCs
(P < 0.01). Moreover, a similar change in levels of RAS,
HER-2, and P53 was observed in ADSCs cocultured with

WU et al. / Turk J Biol

Figure 4. MCF-7–secreted exosomes changed mRNA levels of RAS, P53, and HER-2 in ADSCs. A: Compared with the control group,
MCF-7–secreted exosomes increased mRNA levels of RAS and HER-2 while reducing the level of P53 in ADSCs; exosome L: 100 µg/
mL; exosome H: 200 µg/mL. B: Compared with the control group, exosomes from LPS- or poly (I:C)-treated MCF-7 cells significantly
increased mRNA levels of RAS and HER-2, and reduced the level of P53 in ADSCs. 1: Control group (ADSCs without exosome
treatment); 2: ADSCs treated with 100 µg/mL exosomes from LPS-stimulated MCF-7 cells; 3: ADSCs treated with 200 µg/mL exosomes
from LPS-stimulated MCF-7 cells; 4: ADSCs treated with 100 µg/mL exosomes from poly (I:C)-stimulated MCF-7 cells; 5: ADSCs
treated with 200 µg/mL exosomes from poly (I:C)-stimulated MCF-7 cells. **P < 0.01 compared to group 1. Data are shown as the means
of three parallel experiments.

exosomes from LPS- or poly (I:C)-treated MCF-7 cells (P
< 0.01, Figures 5C and 5D).
4. Discussion
Several recent studies (Muehlberg et al., 2009; Kucerova
et al., 2011; Kim et al., 2013) confirm that ADSCs
stimulate breast cancer cell growth and migration in

vitro, and coinjection of ADSCs with breast cancer cells
promotes the growth of xenograft tumors in mice. On the
other hand, it has been previously demonstrated ADSCs
are prone to differentiating into carcinoma-associated
fibroblast-like cells in the presence of tumor-derived
factors, and change into tumor stroma when treated with
lung cancer cells (Jotzu et al., 2011; Park et al., 2013).
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Figure 5. MCF-7–secreted exosomes altered the expression of RAS, P53, and HER-2 in ADSCs. A: Representative protein
bands, exosome L: 100 µg/mL; exosome H: 200 µg/mL. B: MCF-7–secreted exosomes significantly increased levels of RAS
and HER-2, and reduced the level of P53 in ADSCs compared with the control group. 1: Control group (ADSCs without
exosome treatment), 2: ADSCs treated with 100 µg/mL exosomes, 3: ADSCs treated with 200 µg/mL exosomes. **P < 0.01
compared to group 1. Data are shown as the means of three parallel experiments. C: Representative protein bands. D:
Exosomes significantly increased levels of RAS and HER-2, and reduced the level of P53 in ADSCs compared with that of
control group. 1: Control group (ADSCs without exosomes treatment), 2: ADSCs treated with 100 µg/mL exosomes from
LPS-stimulated MCF-7 cells. 3: ADSCs treated with 200 µg/mL exosomes from LPS-stimulated MCF-7 cells. 4: ADSCs
treated with 100 µg/mL exosomes from poly (I:C)-stimulated MCF-7 cells. 5: ADSCs treated with 200 µg/mL exosomes
from poly (I:C)-stimulated MCF-7 cells. **P < 0.01 compared to group 1. Data are shown as the means of three parallel
experiments.

These findings indicate that the interaction of ADSCs
with tumor cells could induce significant phenotype and
functional alterations. Other papers suggest inflammation
is involved in the interaction of ADSCs and tumor cells.
For example, both ADSCs and breast cancer cells could
release proinflammatory cytokines such as IL-6 and IL-8
(Kilroy et al., 2007; Senst et al., 2013). ADSCs (Razmkhah
et al., 2010) protect breast cancer cells from host immune
responses by tumor-promoting factors like insulin-like
growth factor-1 (IGF-1), hepatocyte growth factor (HGF),
vascular endothelial growth factor (VEGF), and IL-8. In
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breast cancer tissues, IGF-1 and IL-8 mRNAs are 28.6- and
56-fold more expressed in high-stage compared to lowstage patients; in ADSCs, relative quantifications of VEGF,
IL-8, HGF, and IGF-1 were approximately 2-fold higher
in patients than in controls. Recent research (Walter et
al., 2009; Welte et al., 2012) further notes that stromalcell–derived IL-8 promotes invasion of cancer cells, and
depletion of IL-6 in ADSCs abrogates its stimulatory effect
on migration and invasion of breast tumor cells. However,
no more detailed mechanisms of the interaction of ADSCs
with breast cancer cells are discussed.
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To acquire the traits for performing multiple steps
of metastasis, cancer cells usually undergo EMT. EMT
is an imperative process in cancer metastasis and is
characterized by a loss of E-cadherin expression and
increased levels of mesenchymal markers, including
N-cadherin and vimentin (Kumar et al., 2015). TGFβ1Smad is a ubiquitous signaling pathway that participates
in the pathological process of numerous diseases. A
recent work proves overactive TGFβ1-Smad accelerates
the formation of EMT (Jiang et al., 2015). The binding of
TGFβ1 to its receptors induces activated serine/threonine
kinases and phosphorylated Smad2/Smad3 (heteromeric
complexes). The complexes translocate into the nucleus
and promote transcription of several EMT-associated
genes, including SNAIL, SLUG, and TWIST1 (Javelaud
et al., 2011). Kallergi et al. (2011) found that Vimentin,
TWIST1, SNAIL, and SLUG are expressed in circulating
tumor cells of early metastatic breast cancer patients. In an
in vitro study, Snail-depleted cancer-associated fibroblasts
(CAF) failed to obtain myofibroblastic traits in response
to TGFβ1, and human breast cancers with Snail1(+) CAF
tended to exhibit desmoplastic areas with anisotropic
fibers, lymph node involvement, and poorer outcomes
(Stanisavljevic et al., 2015). Accordingly, Twist knockdown
in WT tumor cells increases E-cadherin and reduces cell
invasion and metastasis, while Twist overexpression in KO
cells decreases E-cadherin and increases cell invasion (Qin
et al., 2009).
P53 is a tumor suppressor that detects oncogenic events
in cancer cells and eliminates them through apoptosis,
while the HER-2 gene is a protooncogene that usually has
the strongest prognostic value in breast cancer (Khurshid et
al., 2014). RAS is well known for its function as a molecular
switch by cycling between GTP-bound active and GDPbound inactive forms in intracellular signaling pathways
that control cell growth, differentiation, and survival
(Shima et al., 2015). Previous studies (Lo et al., 2013; Rubio
et al., 2013) proved increased adipogenic differentiation
of ADSCs was correlated with downregulation of P53 in
a time-dependent manner, and deficiency of P53 alone in
ADSCs promoted leiomyosarcoma-like tumors in vivo.
Moreover, RAS has been demonstrated to be involved in
reciprocal signaling between ADSCs and tumor cells. RAStransfected ADSCs lose their ability to differentiate into
adipocytes and instead differentiate into cells characterized
by cytoplasmic granules, extensive nonspecific esterase
activity, and anchorage-independent growth (Tzen et al.,
1990). It has been previously confirmed (Abd Elmageed
et al., 2014) that prostate-cancer–derived exosomes
containing H-ras and K-ras transcripts, as well as the
RAS superfamily of GTPases, induce the tumorigenic
reprogramming of ADSCs.
LPS, a component of the outer membrane in gramnegative bacteria, triggers a Toll-like receptor-4 (TLR4)

immune response and plays a significant role in innate
and adaptive immunity. Poly (I:C), a synthetic analogue
of double-stranded RNA, is the agonist of TLR3 and is
usually used as a vaccine adjuvant to enhance innate and
adaptive immune responses (Durai et al., 2015; Reisinger
et al., 2015). To date, these reagents have been widely used
to stimulate various cells to produce pro-inflammatory
cytokines that imitate an inflammation environment in
vivo. In the present work, we first investigated the effects
of ADSC-derived exosomes on EMT-relevant proteins
of MCF-7 in vitro, and the influence of MCF-7–derived
exosomes on tumor-cell–associated markers in ADSCs.
The results showed that ADSC-derived exosomes
significantly increase EMT-relevant regulators both at
the protein and mRNA levels, while MCF-7–released
exosomes observably alter oncogene expression at both
protein and mRNA levels, leading to increased levels
of RAS and HER-2 and decreased levels of P53. Finally,
these molecules showed similar tendencies in variation
in cells that received exosome treatment in the presence
of LPS or poly (I:C) compared to cells treated with
exosomes in the absence of LPS or poly (I:C). However,
in consideration of human experimental ethics, we were
unable to obtain the direct effects of autogenous ADSCs
(or MCF-7) on MCF-7 (or ADSC) properties in vivo; the
effect may be measured in animal models for our next
study. Interestingly, Mukherjee et al. (2014) found that
primary breast cancer stem cells showed an increased
cell migration ability with the development of tumor
progression, and a gradual decrease in the expression
levels of E-cadherin protein with increasing stages of
breast cancer in vivo. These results are consistent with our
present data. Several recent published studies investigated
ADSCs–MCF-7 communication in vitro. For example,
Tang et al. (2015) showed that mesenchymal stem cells
(MSCs) are recruited to malignant fluids by a tumorcell–derived chemokine-mediated signaling pathway on
the MSC. TGF-β can alter tight junction formation in the
mammary epithelium and induce a number of embryonic
signaling pathways, including the Wnt, Notch, and Hh
pathways. SNAI1 and SNAI2/Slug (Snail) association with
SMAD3 and SMAD4 in the TGF-β signaling pathway
initiates cancer growth and metastasis during EMT by
inhibiting or suppressing transcription of E-cadherin
(Takebe et al., 2011). McAndrews et al. (2015) observed
that MSCs induce directional migration of invasive breast
cancer cells through TGF-β. Accordingly, these findings
suggest the communication of ADSCs with MCF-7 is, at
least in part, via metastasis-related signaling pathways.
It should be noted that there are conflicting reports on
ADSCs that describe both the promotion and inhibition
of cancer progression, which may be closely related to
immunoregulatory activity, subtype of ADSCs, and tumor
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microenvironment in vivo. A previous study (Torsvik et
al., 2010) concludes that ADSCs inhibit tumor growth
by increasing inflammatory inﬁltration, while another
concludes that some cancers may originate from normal
stem cells (Magee et al., 2012). To date, it is apparent that
stem cells play multiple roles in immunoregulation, which
is evidenced by their ability to act as immune suppressors
or stimulators, and their expression of MHC-II can either
increase or decrease following IFN-gamma stimulation
(Chen et al., 2007). Moreover, ADSCs are a heterogeneous
cell population that may contain stromal cells, MSCs, and
endothelial progenitors. It is possible that only a subset
of MSCs within a population possesses multipotent
diﬀerentiation potential and promotes tumorigenesis,
while another subset inhibits tumorigenesis. For example,
increased tumor-homing properties were found in a

specific MSC subpopulation that exhibited increased
expression of integrins (Bolontrade et al., 2012).
Additionally, the tumor microenvironment may influence
immunosuppressive properties of MSCs, as diﬀerentiated
MSCs in the tumor microenvironment may show diﬀerent
allogeneic or xenogeneic responses (Zhang et al., 2012).
Based on the results, it can be concluded that in
vitro interaction of MCF-7 cells with ADSCs results in
increased levels of a series of metastasis-related functional
proteins in MCF-7 cells, as well as enhanced expression of
oncogenes in ADSCs.
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